82.06
1.90 (2.37%)
| Previous Close | 80.16 |
| Open | 83.16 |
| Volume | 211 |
| Avg. Volume (3M) | 934 |
| Market Cap | 4,069,133,824 |
| Price / Earnings (TTM) | 4.31 |
| 52 Weeks Range | |
| Earnings Date | 28 May 2025 |
| Profit Margin | 10.39% |
| Operating Margin (TTM) | 18.44% |
| Diluted EPS (TTM) | 19.03 |
| Quarterly Revenue Growth (YOY) | 6.30% |
| Quarterly Earnings Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 34.50% |
| Current Ratio (MRQ) | 2.10 |
| Operating Cash Flow (TTM) | 762.40 M |
| Levered Free Cash Flow (TTM) | 229.68 M |
| Return on Assets (TTM) | 3.88% |
| Return on Equity (TTM) | 5.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (GB) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | COOPER COMPANIES INC COOPER ORD | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
|
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 0.62% |
| % Held by Institutions | 102.58% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |